GERN Q2 2020 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$43,000-57.4% YoY

Gross Profit

-$11M-25120.9% margin

Operating Income

-$17M-38981.4% margin

Net Income

-$16M-36800.0% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

-17.3%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$13M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$275M

Total Liabilities

$24M

Stockholders' Equity

$251M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43,000	$101,000	-57.4%
Gross Profit	-$11M	-$10M	-7.7%
Operating Income	-$17M	-$15M	-10.1%
Net Income	-$16M	-$14M	-11.1%